Li et al.: UPF1 Inhibits Gastric Cancer Progression Accepted: May 21, 2017
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution IRUFRPPHUFLDOSXUSRVHVDVZHOODVDQ\GLVWULEXWLRQRIPRGLÀHGPDWHULDOUHTXLUHVZULWWHQSHUPLVVLRQ
Original Paper
The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1 Li Lia Yingying Genga Ru Fenga4LQTLQ=KXa Bei Miaoa-LDQJ&DRb Sujuan Feia Department of Gastroenterology, b'HSDUWPHQWRI+HPDWRORJ\WKH$IÀOLDWHG+RVSLWDORI;X]KRX 0HGLFDO8QLYHUVLW\;X]KRX&KLQD
Gastric cancer is the second leading cause of cancer worldwide [1]. Although the recent advances are acquired in gastric cancer treatment, majority of patients remain incurable